Chemiluminescence diagnostic platform for quantitative and qualitative analysis of biomarkers in patient samples. Delivers sensitive detection capabilities for clinical laboratory and point-of-care applications.
Manufactured by
Guangzhou Wondfo Biotech Co., Ltd.
Guangzhou, Guangdong, China
Guangzhou Wondfo Biotech Co., Ltd. founded in 1992 and headquartered in Guangzhou science city. Wondfo focuses on the R D, manufacturing, sales and service of IVD industry , providing professional rapid diagnosis and chronic disease management solutions. Wondfo has 9 technology platforms . Our rapid diagnostic devices and reagents span a wide spectrum, including cardiovascular diseases, diabetes, renal functions, respiratory issues, fertility, DOA, infections, tumors, etc . We provide services to over 150 countries and regions . In 2015, Wondfo was listed on the Shenzhen Stock Exchange, becoming the first public company in POCT in China .
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Xenta Biomedical Science Co.,Ltd
China · 2 relevant products
Shenzhen YHLO Biotech Co., Ltd.
China · 3 relevant products
Jiangsu Sunlant Bioengineering Co., Ltd.
China · 1 relevant product
21 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →1 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 32 closest product alternatives
Xenta Biomedical Science Co.,Ltd · China
A diagnostic platform featuring high sensitivity and wide detection menu that comprehensively covers critical care, cardiovascular and cerebrovascular diseases, and other key clinical areas. The platform is widely applied in clinical departments such as laboratory medicine, emergency medicine, and ICU, while also suitable for diverse scenarios including primary healthcare facilities, health examination centers, and reproductive centers.
Shenzhen YHLO Biotech Co., Ltd. · China
A comprehensive technology platform utilizing chemiluminescence immunoassay methodology for in vitro diagnostic testing. The platform enables sensitive and specific detection of various clinical markers including reproductive, autoimmune, infectious disease, and metabolic parameters.
Xenta Biomedical Science Co.,Ltd · China
A proprietary dry-phase photoactivated chemiluminescence technology platform for point-of-care testing. Covers cardiovascular, inflammatory, tumor marker, hormone, and infectious disease diagnostics.
29 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products